{Reference Type}: Journal Article
{Title}: Evidence-based treatment for gynoid lipodystrophy: A review of the recent literature.
{Author}: Pérez Atamoros FM;Alcalá Pérez D;Asz Sigall D;Ávila Romay AA;Barba Gastelum JA;de la Peña Salcedo JA;Escalante Salgado PE;Gallardo Palacios GJ;Guerrero-Gonzalez GA;Morales De la Cerda R;Ponce Olivera RM;Rossano Soriano F;Solís Tinoco E;Welsh Hernández EC;
{Journal}: J Cosmet Dermatol
{Volume}: 17
{Issue}: 6
{Year}: Dec 2018
{Factor}: 2.189
{DOI}: 10.1111/jocd.12555
{Abstract}: Gynoid lipodystrophy (GLD) is a structural, inflammatory, and biochemical disorder of the subcutaneous tissue causing alterations in the topography of the skin. Commonly known as "cellulite," GLD affects up to 90% of women, practically in all stages of the life cycle, beginning in puberty. It is a clinical condition that considerably affects the patients' quality of life. It is a frequent reason for consultation, although the patients resort to empirical, improvised, nonevidence-based treatments which discourage and can be a source of frustration not only because of the lack of results but also due to the complications derived from those treatments. In this article, a panel of experts from different specialties involved in the management of this clinical skin disorder presents the results of a systematic literature search and of the consensus discussion of the evidence obtained from different treatments currently available. The analysis was divided into topical, systemic, noninvasive, and minimally invasive treatments.